On November 10, 2025, Edgewise Therapeutics, Inc. appointed Michael Nofi as Chief Financial Officer, succeeding Michael Carruthers who retired on the same day without disagreement. Nofi's annual salary is $465,000, with a potential bonus and stock options totaling 262,500 shares.